Institute for Biomedicine
Institute for Biomedicine
Our starting point is always the individual and their unique characteristics, then comes the laboratory and finally we go back to people: this is how our research work is undertaken. We study how genetic heritage, the environments in which we live and our lifestyles affect the appearance and development of diseases as well as how these factors influence our health.
Data Activity Report 2020/2021
“Without understanding molecules we can only have a very sketchy understanding of life itself.” F. Cricksee more
"It is easy to lie with statistics. It is hard to tell the truth without it" A. Dunkelssee more
News & Events
02 December 2021
Lo studio CHRIS riprende il follow-up dei 13 mila partecipanti
Dopo la sospensione imposta dalla pandemia, il centro CHRIS dell’Ospedale di Silandro torna a popolarsi. Per gli oltre 13 mila abitanti della Val Venosta entrati a far parte dello studio tra il 2011 e ...
13 October 2021
CHRIS COVID-19 study protocol available to the scientific community
Available in Open Access, it represents a resource for researchers who want to replicate similar studies.
14 October 2021
EPIC at the NOI project fair
The yearly EFRE project fair on October 22nd is the perfect opportunity to meet us, we are presenting EPIC at booth 13.
28 September 2021
New headquarters for the Institute for Biomedicine
From mid-2022, the Institute for Biomedicine will open its new headquarters in the NOI Techpark: the interview with our director Peter P. Pramstaller.
24 August 2021
Covid-19 in Val Gardena
Uno studio dell’Azienda Sanitaria e di Eurac Research individua diversi fattori legati alla positività a Covid-19. La ricerca si è svolta nella primavera 2020 in Val Gardena (BZ).
08 July 2021
Large genomic analysis highlights COVID-19 risk factors
A new worldwide study published in Nature reveals 13 loci that are strongly associated with infection or severe COVID-19. The Institute of Biomedicine contributed data from the CHRIS Covid 19 study ...
Epigenetics of Immunity in CancerDuration: September 2019 - December 2022Funding:
CHRIS-2D: a Dynamic Data infrastructure for biomedical research and innovation in South TyrolDuration: June 2020 - December 2022Funding:
Innovative therapies for cardiovascular disease.Duration: October 2020 - October 2022Funding:
Multidisciplinary Training in Chronic Kidney Disease: from genetic modifiers to drug discoveryDuration: December 2019 - December 2023Funding:
MAGAZINE Science Stories that Inspire
In Alto Adige la ricerca biomedica che non ti aspetti
Per lo studio di popolazione CHRIS di Eurac Research in Val Venosta si apre un nuovo capitolo
Covid-19: links between genes and disease severity
Bolzano research centre among institutions involved in a study to reveal human genome locations associated with Covid-19 severity